Friday, August 27, 2021 7:15:08 PM
The referenced list is continually being updated by the SEC and should not be perceived as final at this time.
If there is anything further that we can do for you or if you have additional questions related to this topic or something else, please do not hesitate to respond back to this message, chat or call us anytime day or night at 800-669-3900. We appreciate your business!
Best,
Dale Delisle
Client Services
TD Ameritrade
1-800-669-3900
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM